Oncology Nurses' Role in Cell and Gene Therapy: Future Expansions and Evolving Foundations [0.03%]
细胞和基因疗法的现状与未来—— oncology护士的角色变迁及应对策略
Kristin Marie Ferguson,Joaquin Buitrago
Kristin Marie Ferguson
During the past decade, cell and gene therapies have moved from experimental interventions to integral components of contemporary oncology nursing practice. In response to the continuously changing landscape and the widening. ...
Nursing Considerations for CAR T-Cell Therapy: Management of Cytokine Release Syndrome and Immune Effector Cell-Associated Neurotoxicity Syndrome [0.03%]
CAR-T细胞治疗的护理问题：细胞因子释放综合征与免疫效应细胞相关神经毒性综合征的管理
Demi M Miller
Demi M Miller
Background: Chimeric antigen receptor (CAR) T-cell therapy is a promising treatment for certain hematologic malignancies, but many nurses are not trained in caring for two common side effects, cytokine release syndrome (C...
Lacking Policy, Education, and a Plan to Support Bispecific T-Cell Engager Therapy: Nursing-Led Change at an Academic Medical Center [0.03%]
缺乏双特异性T细胞接合器疗法的政策、教育和计划的支持：学术医学中心以护理为主的变革
Kristin Soper,Lauren M Squires
Kristin Soper
Background: Many large cancer centers have implemented new policies and procedures to manage patients receiving bispecific T-cell engager (BTCE) therapy. ...
Cellular Therapy Nurse Experts as a Conduit Between Hospital Clinical, Business Operations, and Revenue Cycle Teams [0.03%]
细胞治疗护士专家作为医院临床、商业运营和收入周期团队之间的纽带
Claire White
Claire White
Background: Genetically modified cellular therapies (GMCTs) are increasingly used to treat imminently life-threatening illnesses. However, these therapies are associated with substantial costs, require specialized care, a...
Lessons Learned: Operationalizing Chimeric Antigen Receptor T-Cell Therapy in the Community Oncology Private Practice Healthcare Setting [0.03%]
CAR-T细胞治疗在社区肿瘤私立医疗环境中的应用经验教训分析研究报告摘要
Martie M Steinfeld,Xiaoxiao Zhang,Ashley Todd et al.
Martie M Steinfeld et al.
Background: Chimeric antigen receptor (CAR) T-cell therapy is an established therapy for relapsed or refractory hematologic malignancies. Traditionally, it has been administered in outpatient or inpatient settings at urba...
Navigating Acute and Late-Onset Toxicities After Chimeric Antigen Receptor T-Cell Therapy: A Patient-Centered Nursing Approach [0.03%]
嵌合抗原受体T细胞治疗后急、慢性毒性反应的护理对策——以患者为中心的方法
Karla V Ow
Karla V Ow
Background: Patients with cancer undergoing advanced therapies, such as chimeric antigen receptor (CAR) T-cell therapy, experience complex treatment-related toxicities that require timely recognition and management. Nurse...
Enhancing Safety With a Massive Transfusion Protocol for Patients With Cancer Experiencing Uncontrolled Hemorrhage [0.03%]
癌症患者出血失控的大量输血治疗方案的安全性改进措施
Colleen Villamin,Jeff Beno,Christine Rudzinski Raby et al.
Colleen Villamin et al.
Background: Oncology nurses can recognize and respond to hemorrhagic emergencies across and beyond cellular therapy care in a timely and efficient manner to promote optimal patient outcomes. Massive transfusion protocol (...
Reducing CLABSIs via Antiseptic Barrier Caps Among Patients Undergoing Transplantation or Cellular Therapy: A Quality Improvement Project [0.03%]
改良移植及细胞治疗患者导管相关血流感染的品管专案：使用消毒隔离接头减少CLABSI率
Sarah Rowland Rutledge,Sarah B Kibbee,Julie Kleber et al.
Sarah Rowland Rutledge et al.
Background: Central line-associated bloodstream infections (CLABSIs) pose serious risks for patients undergoing stem cell transplantation and cellular therapy and remain a challenge for healthcare teams and facilities. ...
Michelle Cha
Michelle Cha
Background: Since the 1990s, clinical trials have studied the feasibility, safety, efficacy, and challenges of using gene therapy to cure hemophilia. In 2022, the U.S. Food and Drug Administration approved the first comme...
Osborn Owusu Ansah,Ebenezer Akore Yeboah
Osborn Owusu Ansah
At the bedside, we have the privilege of witnessing moments that rarely make their way into study findings. The quiet fears voiced after clinic visits, the trade-offs patients make between treatment and work, and the social a. ...